Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Murali K. Mamidi"'
Autor:
Murali K. Mamidi, Jifeng Huang, Kazuhito Honjo, Ran Li, Edlue M. Tabengwa, Indira Neeli, Nar’asha L. Randall, Manasa V. Ponnuchetty, Marko Radic, Chuen-Miin Leu, Randall S. Davis
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Immunotherapeutic targeting of surface regulatory proteins and pharmacologic inhibition of critical signaling pathways has dramatically shifted our approach to the care of individuals with B cell malignancies. This evolution in therapy reflects the c
Externí odkaz:
https://doaj.org/article/4bd75577d0ab4e1383a1ce91c0a9a747
Autor:
Murali K. Mamidi, Hasan Mahmud, Guru P. Maiti, Mariana T. Mendez, Stacey M. Fernandes, Sara K. Vesely, Jennifer Holter-Chakrabarty, Jennifer R. Brown, Asish K. Ghosh
Publikováno v:
Leukemia. 36:1806-1817
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26c9cae63e553b4c02f8b9a7e59b583d
https://doi.org/10.1038/s41375-022-01595-0
https://doi.org/10.1038/s41375-022-01595-0
Autor:
Murali K, Mamidi, Hasan, Mahmud, Guru P, Maiti, Mariana T, Mendez, Stacey M, Fernandes, Sara K, Vesely, Jennifer, Holter-Chakrabarty, Jennifer R, Brown, Asish K, Ghosh
Publikováno v:
Leukemia. 36(7)
Idelalisib targets PI3Kδ in the BCR pathway generating only a partial response in CLL patients, indicating that the leukemic cells may have evolved escape signals. Indeed, we detected increased activation of AKT accompanied by upregulation of MYC/BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64d063eb6dce5f6b9b8196e70070d05b
https://pubmed.ncbi.nlm.nih.gov/35568768
https://pubmed.ncbi.nlm.nih.gov/35568768
Publikováno v:
Am J Cancer Res
Chondrosarcoma (CS) is the second most common skeletal malignancy in humans. High-grade CS is aggressive and extremely resistant to chemo- and radio-therapies. The lack of effective treatment options warrants the development of novel therapies. The e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::668103b5b6b9bfc0f0fa47f507edfcf8
https://pubmed.ncbi.nlm.nih.gov/34765312
https://pubmed.ncbi.nlm.nih.gov/34765312
Autor:
Bojian, Liang, Murali K, Mamidi, William E, Samsa, Yuqing, Chen, Brendan, Lee, Qiping, Zheng, Guang, Zhou
Publikováno v:
American journal of translational research. 12(3)
Sox9 is the master transcription factor essential for cartilage development and homeostasis. To investigate the specific role of Sox9 during chondrocyte hypertrophy, we generated a novel Col10a1-Sox9 transgenic mouse model, in which Sox9 is specifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::154ec0ace3a9cbaa12f33bea3ca8e83b
https://pubmed.ncbi.nlm.nih.gov/32269734
https://pubmed.ncbi.nlm.nih.gov/32269734